Co-Author
This page shows the publications co-authored by Craig Surman and Amy Yule.
Connection Strength
0.276
-
Surman C, Ceranoglu A, Vaudreuil C, Albright B, Uchida M, Yule A, Spencer A, Boland H, Grossman R, Rhodewalt L, Fitzgerald M, Biederman J. Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical Trial. J Clin Psychopharmacol. 2019 Jan/Feb; 39(1):28-38.
Score: 0.217
-
Joshi G, DiSalvo M, Wozniak J, Ceranoglu TA, Yule A, Surman C, Fried R, Galdo M, Hoskova B, Belser A, Biederman J. A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder. World J Biol Psychiatry. 2020 04; 21(4):274-290.
Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.